Current Research on the Relationships Between Oxytocin and the Immune System: An Updated Study

2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.66224/ari.81.3.3451
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

A neuropeptide that has historically been linked to social bonding, childbirth, and breastfeeding; oxytocin has become a significant immune system regulator. Oxytocin also provides relaxation during pregnancy by lowering blood pressure. At the time of delivery, it increases uterine contractions, making childbirth easier. During the postpartum breastfeeding period, it helps milk flow by causing the milk ducts in the breasts to contract. Its function in controlling immune responses, affecting inflammation, and preserving immunological homeostasis has been emphasized by recent research. The complex connections between oxytocin and the immune system are examined in this study, with particular attention paid to how it interacts with immune cells, produces cytokines, and controls pro- and anti-inflammatory pathways. Numerous immune-related problems, including as autoimmune diseases, chronic inflammation, and neurodegenerative ailments, are linked to dysregulation of oxytocin signalling, which can be caused by altered receptor function or reduced production. Furthermore, oxytocin’s therapeutic potential in lowering inflammation and reestablishing immunological balance offers promising prospects for the treatment of immune dysfunction. The study highlights the need for clinical studies to assess oxytocin’s therapeutic uses as well as more investigation into the molecular, genetic, and epigenetic pathways underpinning its immune-modulatory activities. Through the synthesis of current research findings and the identification of existing gaps, this work seeks to provide guidance for future research and therapeutic applications while also deepening our understanding of oxytocin’s involvement in immune modulation. This study lays the groundwork for investigating oxytocin-based treatments to treat illnesses linked to the immune system and enhance general immunological health by deepening our understanding of the function of oxytocin in immune regulation.